Skip to main content
FinSpry Logo
FinSpry
ZBH logo
ZBH
(NYSE)
Zimmer Biomet Holdings, Inc.
$85.38-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Zimmer Biomet Holdings (ZBH) Stock Price & Financial Analysis

Zimmer Biomet Holdings Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$84.15 - $86.82
52-Week High$108.29
52-Week Low$79.12
Open$85.25
Volume2.57M
Average Volume (3M)2.54M
Market Cap16.85B
Shares Outstanding195.80M
P/E Ratio (TTM)22.14
Forward P/E26.61
Price to Sales (P/S)2.00
Price to Book (P/B)1.33
EV/EBITDA10.36
Revenue (TTM)8.41B
Net Income (TTM)761.30M
Free Cash Flow (TTM)1.48B
EPS (TTM)$3.85
Profit Margin9.05%
Operating Margin16.86%
Return on Equity (ROE)6.01%
Debt to Equity0.59
50-Day MA$89.98
200-Day MA$94.44
52-Week Change-18.98%
Annual Dividend$0.96
Dividend Yield1.12%
Payout Ratio24.94%
Last Dividend Ex-DateMar 31, 2026

Frequently Asked Questions About Zimmer Biomet Holdings

What is the current stock price for ZBH?

As of the latest trading session, ZBH stock trades at $86.08. The 52-week range is $79.12–$108.29, with a day range of $84.14–$86.82.

What is the P/E ratio for ZBH?

Zimmer Biomet Holdings's trailing P/E ratio is 22.1, meaning investors pay $22.1 for every $1 of annual earnings. The forward P/E is 26.6, reflecting analyst expectations for future earnings. Zimmer Biomet Holdings operates in the Healthcare sector.

Does ZBH pay dividends?

Yes, Zimmer Biomet Holdings pays a 1.12% annual dividend yield ($0.96 per share). The payout ratio is 24.9%. The last ex-dividend date was 2026-03-31.

What do analysts recommend for ZBH?

Based on 9 analysts, the consensus for ZBH is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ZBH?

Zimmer Biomet Holdings's market capitalization is $16.85B, classifying it as a large-cap company. Zimmer Biomet Holdings operates in the Healthcare sector within the Medical Devices industry.